Notably, the risk of premature ovarian failure was significantly higher in BRCA2 carriers than in BRCA1 carriers (46.8% vs. 32.7%; p < 0.001), but there was no significant difference in risk between non-carrier controls and either BRCA1 carriers or BRCA2 carriers [155]. The gene discussed is BRCA1; the disease is primary ovarian failure.